immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy

Protein-based therapeutics can activate the adaptive immune system and lead to the production of neutralizing antibodies and to cytotoxic-T-cell-mediated clearance of the treated cells. Here, we show that the sequential use of immune-orthogonal orthologues of the CRISPR-associated protein 9 (Cas9) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, Ana M., Palmer, Nathan, Alemán, Fernando, Chen, Genghao, Pla, Andrew, Jiang, Ning, Chew, Wei Leong, Law, Mansun, Mali, Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783354/
https://www.ncbi.nlm.nih.gov/pubmed/31332341
http://dx.doi.org/10.1038/s41551-019-0431-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783354/
https://www.ncbi.nlm.nih.gov/pubmed/31332341
http://dx.doi.org/10.1038/s41551-019-0431-2

Ejemplares similares